Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Eupraxia Pharmaceuticals Inc. (EPRX) had Debt to Capital Ratio of 0.01 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-13.26M |
|
-- |
|
-- |
|
$15.96M |
|
$-15.96M |
|
$3.32M |
|
$-12.64M |
|
$-12.64M |
|
$-12.65M |
|
$-12.65M |
|
$-12.65M |
|
$-12.65M |
|
$-15.96M |
|
$-15.87M |
|
56.71M |
|
56.71M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$142.13M |
|
$1.16M |
|
$3.23M |
|
$145.35M |
|
$7.36M |
|
$1.80M |
|
$1.80M |
|
$9.17M |
|
$106.45M |
|
$136.19M |
|
$136.19M |
|
61.81M |
|
| Cash Flow Statement Financials | |
$-10.15M |
|
$-80.05M |
|
$68.58M |
|
$80.56M |
|
$58.50M |
|
$-22.06M |
|
$2.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.30 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.01 |
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.89% |
|
-9.29% |
|
-8.71% |
|
-9.17% |
|
$2.20 |
|
$-0.18 |
|
$-0.18 |
|